BACKGROUND: Evidence is accumulating that youth who try Electronic Nicotine Delivery Systems (ENDS, e-cigarettes) may go on to try cigarettes. This analysis examines the bidirectional patterns of ENDS and cigarette use among US youth over one year and uses propensity score matching (PSM) to examine frequency of ENDS use on changes in cigarette smoking. METHODS: Our analysis included 11 996 participants who had two waves of available data (Wave 1 [W1] 2013-2014; Wave 2 [W2] 2014-2015) drawn from the longitudinal Population Assessment of Tobacco and Health Study. Cross-sectional weighted prevalence estimates are reported for cigarettes and ENDS. We used PSM to estimate the likelihood of ENDS use at W1 and to draw matched analytic samples, then used regression (logistic or linear) models to examine the effect of W1 ENDS use on W2 cigarette smoking. All statistical tests were two-sided. RESULTS: In weighted analyses, 69.3% of W1 past-30-day cigarette smokers exhibited past-30-day smoking at W2; 42.2% of W1 past-30-day ENDS users were using ENDS at W2. W1 ever use of either product was similarly associated with W2 new use of the other product. Unweighted PSM models indicated W1 cigarette-naïve ENDS use was associated with W2 ever-cigarette smoking (n = 676; adjusted odds ratio = 3.21, 95% confidence interval [CI] = 1.95 to 5.45, P < .001); W1 ever-ENDS use did not affect change in cigarette frequency at W2 (n = 1020, beta = 0.31, 95% CI = -0.76 to 1.39, P = .57); 1-5 days ENDS use compared with ever, no past-30-day ENDS use was associated with a statistically significant decrease of W2 smoking days (n = 256, beta = -2.64, 95% CI = -4.96 to -0.32; P = .03); and W1 6+ day ENDS users did not show a decrease in frequency of cigarette smoking. CONCLUSIONS: Ever-ENDS use predicts future cigarette smoking, and frequency of ENDS use has a differential impact on subsequent cigarette smoking uptake or reduction. These results suggest that both cigarettes and ENDS should be targeted in early tobacco prevention efforts with youth.
BACKGROUND: Evidence is accumulating that youth who try Electronic Nicotine Delivery Systems (ENDS, e-cigarettes) may go on to try cigarettes. This analysis examines the bidirectional patterns of ENDS and cigarette use among US youth over one year and uses propensity score matching (PSM) to examine frequency of ENDS use on changes in cigarette smoking. METHODS: Our analysis included 11 996 participants who had two waves of available data (Wave 1 [W1] 2013-2014; Wave 2 [W2] 2014-2015) drawn from the longitudinal Population Assessment of Tobacco and Health Study. Cross-sectional weighted prevalence estimates are reported for cigarettes and ENDS. We used PSM to estimate the likelihood of ENDS use at W1 and to draw matched analytic samples, then used regression (logistic or linear) models to examine the effect of W1 ENDS use on W2 cigarette smoking. All statistical tests were two-sided. RESULTS: In weighted analyses, 69.3% of W1 past-30-day cigarette smokers exhibited past-30-day smoking at W2; 42.2% of W1 past-30-day ENDS users were using ENDS at W2. W1 ever use of either product was similarly associated with W2 new use of the other product. Unweighted PSM models indicated W1 cigarette-naïve ENDS use was associated with W2 ever-cigarette smoking (n = 676; adjusted odds ratio = 3.21, 95% confidence interval [CI] = 1.95 to 5.45, P < .001); W1 ever-ENDS use did not affect change in cigarette frequency at W2 (n = 1020, beta = 0.31, 95% CI = -0.76 to 1.39, P = .57); 1-5 days ENDS use compared with ever, no past-30-day ENDS use was associated with a statistically significant decrease of W2 smoking days (n = 256, beta = -2.64, 95% CI = -4.96 to -0.32; P = .03); and W1 6+ day ENDS users did not show a decrease in frequency of cigarette smoking. CONCLUSIONS: Ever-ENDS use predicts future cigarette smoking, and frequency of ENDS use has a differential impact on subsequent cigarette smoking uptake or reduction. These results suggest that both cigarettes and ENDS should be targeted in early tobacco prevention efforts with youth.
Authors: Adam M Leventhal; David R Strong; Matthew G Kirkpatrick; Jennifer B Unger; Steve Sussman; Nathaniel R Riggs; Matthew D Stone; Rubin Khoddam; Jonathan M Samet; Janet Audrain-McGovern Journal: JAMA Date: 2015-08-18 Impact factor: 56.272
Authors: Thomas A Wills; James D Sargent; Frederick X Gibbons; Ian Pagano; Rebecca Schweitzer Journal: Tob Control Date: 2016-08-19 Impact factor: 7.552
Authors: Andrea C Villanti; Jennifer L Pearson; Allison M Glasser; Amanda L Johnson; Lauren K Collins; Raymond S Niaura; David B Abrams Journal: Nicotine Tob Res Date: 2017-11-01 Impact factor: 4.244
Authors: René A Arrazola; Tushar Singh; Catherine G Corey; Corinne G Husten; Linda J Neff; Benjamin J Apelberg; Rebecca E Bunnell; Conrad J Choiniere; Brian A King; Shanna Cox; Tim McAfee; Ralph S Caraballo Journal: MMWR Morb Mortal Wkly Rep Date: 2015-04-17 Impact factor: 17.586
Authors: Ahmed Jamal; Andrea Gentzke; S Sean Hu; Karen A Cullen; Benjamin J Apelberg; David M Homa; Brian A King Journal: MMWR Morb Mortal Wkly Rep Date: 2017-06-16 Impact factor: 17.586
Authors: Cassandra A Stanton; Eva Sharma; Elizabeth L Seaman; Karin A Kasza; Kathryn C Edwards; Michael J Halenar; Kristie A Taylor; Hannah Day; Gabriella Anic; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Lisa D Gardner; Hoda T Hammad; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland Journal: Tob Control Date: 2020-05 Impact factor: 7.552
Authors: Lindsay M Squeglia; Matthew C Fadus; Erin A McClure; Rachel L Tomko; Kevin M Gray Journal: J Child Adolesc Psychopharmacol Date: 2019-04-22 Impact factor: 2.576
Authors: Kathleen R Case; Josephine T Hinds; MeLisa R Creamer; Alexandra Loukas; Cheryl L Perry Journal: J Adolesc Health Date: 2019-08-31 Impact factor: 5.012
Authors: Grace Kong; Benjamin W Chaffee; Ran Wu; Suchitra Krishnan-Sarin; Feifei Liu; Adam M Leventhal; Rob McConnell; Jessica Barrington-Trimis Journal: Drug Alcohol Depend Date: 2022-01-11 Impact factor: 4.852
Authors: Marina Epstein; Jennifer A Bailey; Rick Kosterman; Isaac C Rhew; Madeline Furlong; Sabrina Oesterle; Sean Esteban McCabe Journal: Addiction Date: 2021-02-03 Impact factor: 6.526